Daily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatoma
NCT07476794
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
118
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
Daily TMZ
Sponsor
Sunnybrook Health Sciences Centre